Full Market Access
Strategic Due Diligence
Market Access Strategy
Digital Health Applications (DiGA) & Digital Pharma
EU-HTA: European Health Technology Assessment
Pharma & Biotech
Digital Health Provider
EU5: Commercial assessment of licensed products for the five major EU markets
Conception of the German market access for two innovatice products
Consistent brand management strengthens the clients base for health delivery
Corporate vision: long-term vision of a hospital
Digital strategy and agenda combine digitization initiatives
Discharge management of a rare disease
How effective integrated care really is
Leadership strategy and executives development
Service cost management: Limiting rising hospital spending
Strategic support and negotiation lead: AMNOG
Trial regulations: strategic support (pursuant to §137e SGB V)
Value assessment and value story for a digital solution
Written statement and oral hearing revise the initial benefit assessment
Agile & Design Thinking
Prof. Matthias P. Schönermark M.D., Ph.D.
Heike Kielhorn-Schönermark, MBA
Would you like to call us?
+49 511 64 68 14 – 0
Would you like to visit us personally?
This is how you find our office in Hannover.
Your request via contact form
* mandatory field
Yes, I agree with the
Discover the latest news from the industry, clearly and comprehensibly presented.
#08 What motivates the World Orphan Drug Congress Europe 2022?
SKC announces EUCOPE membership
European Confederation of Pharmaceutical Entrepreneurs
#07 Outreach Nurse - a profession far too rare
Adoption of the Financial Stabilization Act
Bill is rubber-stamped largely unchanged
Strategic parameters of sheep keeping
Laptop donation to Hanover's pediatric hospital AUF DER BULT
Every donation counts
#06 Rapid diagnosis through artificial intelligence
Hope for the pharmaceutical industry?
Bundesrat censures FinStG draft
to the top